These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 21390503)
1. Over-expressed Fas improves the apoptosis of malignant T-cells in vitro and vivo. Li L; Zhang R; Chen Z; Xue S; Wang X; Ruan C Mol Biol Rep; 2011 Nov; 38(8):5371-7. PubMed ID: 21390503 [TBL] [Abstract][Full Text] [Related]
2. Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression. Prado-Garcia H; Aguilar-Cazares D; Meneses-Flores M; Morales-Fuentes J; Lopez-Gonzalez JS Cancer Immunol Immunother; 2008 Mar; 57(3):325-36. PubMed ID: 17668204 [TBL] [Abstract][Full Text] [Related]
3. Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival. Xu G; Zhang J J Cancer Res Clin Oncol; 2008 Oct; 134(10):1043-9. PubMed ID: 18461366 [TBL] [Abstract][Full Text] [Related]
4. Effects of parathyroid hormone-related protein and macrophage inflammatory protein-1α in Jurkat T-cells on tumor formation in vivo and expression of apoptosis regulatory genes in vitro. Shu ST; Dirksen WP; Lanigan LG; Martin CK; Thudi NK; Werbeck JL; Fernandez SA; Hildreth BE; Rosol TJ Leuk Lymphoma; 2012 Apr; 53(4):688-98. PubMed ID: 21942940 [TBL] [Abstract][Full Text] [Related]
5. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells. Gajate C; Gonzalez-Camacho F; Mollinedo F PLoS One; 2009; 4(4):e5044. PubMed ID: 19352436 [TBL] [Abstract][Full Text] [Related]
6. VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease. Silvestris F; Cafforio P; Tucci M; Del Prete A; Dammacco F Mol Med; 2000 Jun; 6(6):509-26. PubMed ID: 10972087 [TBL] [Abstract][Full Text] [Related]
7. Fas gene mutation in the progression of adult T cell leukemia. Maeda T; Yamada Y; Moriuchi R; Sugahara K; Tsuruda K; Joh T; Atogami S; Tsukasaki K; Tomonaga M; Kamihira S J Exp Med; 1999 Apr; 189(7):1063-71. PubMed ID: 10190897 [TBL] [Abstract][Full Text] [Related]
8. NF kappa B controls the balance between Fas and tumor necrosis factor cell death pathways during T cell receptor-induced apoptosis via the expression of its target gene A20. Malewicz M; Zeller N; Yilmaz ZB; Weih F J Biol Chem; 2003 Aug; 278(35):32825-33. PubMed ID: 12813034 [TBL] [Abstract][Full Text] [Related]
9. Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway. Favre-Felix N; Fromentin A; Hammann A; Solary E; Martin F; Bonnotte B J Immunol; 2000 May; 164(10):5023-7. PubMed ID: 10799856 [TBL] [Abstract][Full Text] [Related]
10. Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis. Dotti G; Savoldo B; Pule M; Straathof KC; Biagi E; Yvon E; Vigouroux S; Brenner MK; Rooney CM Blood; 2005 Jun; 105(12):4677-84. PubMed ID: 15713795 [TBL] [Abstract][Full Text] [Related]
11. CEACAM1 regulates Fas-mediated apoptosis in Jurkat T-cells via its interaction with β-catenin. Li Y; Shively JE Exp Cell Res; 2013 May; 319(8):1061-72. PubMed ID: 23499736 [TBL] [Abstract][Full Text] [Related]
12. Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers. Kassouf N; Thornhill MH Oral Oncol; 2008 Jul; 44(7):672-82. PubMed ID: 17996489 [TBL] [Abstract][Full Text] [Related]
13. The conformational alteration of the mutated extracellular domain of Fas in an adult T cell leukemia cell line. Maeda T; Nakayama S; Yamada Y; Sugahara K; Isomoto H; Tawara M; Yamasaki R; Onimaru Y; Matsushita T; Ohzono Y; Kamihira S Biochem Biophys Res Commun; 2002 Sep; 296(5):1251-6. PubMed ID: 12207908 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of Fas-ligand by neuroblastoma: a novel mechanism of tumor-cell killing. Takamizawa S; Okamoto S; Wen J; Bishop W; Kimura K; Sandler A J Pediatr Surg; 2000 Feb; 35(2):375-9. PubMed ID: 10693700 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of microRNA-128a expression contributes to the apoptosis-resistance of human T-cell leukaemia jurkat cells by modulating expression of fas-associated protein with death domain (FADD). Yamada N; Noguchi S; Kumazaki M; Shinohara H; Miki K; Naoe T; Akao Y Biochim Biophys Acta; 2014 Mar; 1843(3):590-602. PubMed ID: 24316133 [TBL] [Abstract][Full Text] [Related]
17. High level expression of the homeobox gene HB24 in a human T-cell line confers the ability to form tumors in nude mice. Deguchi Y; Kehrl JH Cancer Res; 1993 Jan; 53(2):373-7. PubMed ID: 8093351 [TBL] [Abstract][Full Text] [Related]
18. Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis. Xerri L; Devilard E; Hassoun J; Haddad P; Birg F Leukemia; 1997 Nov; 11(11):1868-77. PubMed ID: 9369420 [TBL] [Abstract][Full Text] [Related]
19. Experimental study on inhibition effects of the XAF1 gene against lung cancer cell proliferation. Yang WT; Chen DL; Zhang FQ; Xia YC; Zhu RY; Zhou DS; Chen YB Asian Pac J Cancer Prev; 2014; 15(18):7825-9. PubMed ID: 25292071 [TBL] [Abstract][Full Text] [Related]
20. Effects of specific antisense oligonucleotide inhibition of Fas expression on T cell apoptosis induced by Fas ligand. Mao H; Liu Q; Zhang J; Gu H; Wang L; Zhou X; Yin H; Zhang L; Xie F; Jiang G Int Immunopharmacol; 2007 Dec; 7(13):1714-22. PubMed ID: 17996681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]